The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ADAPT therapy vs capecitabine bevacizumab in stage IV colorectal cancer: Pooled 10-year survival experience and a phase II study update.
 
Edward H. Lin
Patents, Royalties, Other Intellectual Property - Apomax Biolab
 
Edward Y. Kim
No Relationships to Disclose
 
Ling Wang
No Relationships to Disclose
 
Chirstine Fong
No Relationships to Disclose
 
Veena Shankaran
Research Funding - Amgen (Inst); Castle Biosciences (Inst); Merck (Inst)
 
Xifeng Wu
No Relationships to Disclose
 
Douglas E. Wood
No Relationships to Disclose
 
Raymond Sze Yeung
No Relationships to Disclose
 
Qiang Tian
No Relationships to Disclose